• 1
    Bovet D & Staub A. Action protectrice des éthers phénoliques au cours de l'intoxication histaminique. CRS Soc Biol (Paris) 1937;124:527 549
  • 2
    Lowe E, MacMillan R, Katser M. The antihistamine properties of Benadryl, beta-dimethyl-aminoethyl benzhydryl ether hydrochloride. J Pharmacol Exp Ther 1946;86:229
  • 3
    Simons FE & Simons KJ. The pharmacology and use of H1-receptor-antagonist . N Engl J Med 1994;330:1663 1670
  • 4
    Kulshrestha VK, Gupta PP, Turner P, Wadsworth J. Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol 1978;6:25 29
  • 5
    Van Wauwe J, Awouters F, Neimegeers CJ, et al. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound . Arch Int Pharmacodyn Ther 1981;251:39 51
  • 6
    Roman IJ, Kassem N, Gural RP, Herron J. Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man. Ann Allergy 1986;57:253 256
  • 7
    Juhlin L, De Vos C, Rihoux JP. Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol 1987;80:599 602
  • 8
    Simons FE, McMillan JL, Simons KJ. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540 547
  • 9
    Juhlin L. A comparison of the pharmacodynamics of H1-receptor antagonists as assessed by the induced wheal-and-flare model . Allergy1995;50:24 30
  • 10
    Church MK, Collinson AD, Okayama Y. Antiallergic effects in vitro In: SimonsFER, editor, editors. Histamine and H1-receptor antagonists in allergic disease . New York: Marcel Dekker, 1996:117 144
  • 11
    Charlesworth EN, Massey WA, Kagey-sobotka A, Norman PS, Lichtenstein LM. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964 970
  • 12
    Redier H, Chanez P, De Vos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;9:215 224
  • 13
    Nightingale CH. Treating allergic rhinitis with second-generation antihistamines. Pharmacotherapy 1996;16:905 914
  • 14
    Sim TC & Grant JA. H1-receptor antagonists in chronic urticaria In: SimonsFER, editor, editors. Histamine and H1-receptor antagonists in allergic disease . New York: Marcel Dekker, 1996:273 296
  • 15
    Windbery SL & Lieberman PL. Anaphylaxis and histamine antagonists In: SimonsFER, editor, editors. Histamine and H1-receptor antagonists in allergic disease . New York: Marcel Dekker, 1996:297 327
  • 16
    Sly RM & Kemp JP. American Academy of Allergy and Immunology Committee on DrugsThe use of antihistamines in patients with asthma. J Allergy Clin Immunol 1988;82:481 482
  • 17
    Malick A & Grant JA. Antihistamines in the treatment of asthma. Allergy 1997;99:699 706
  • 18
    Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923 932
  • 19
    Aaronson DW. Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma. Ann Allergy Asthma Immunol 1996;76:440 446
  • 20
    Woosley RL. Cardiac actions of antihistamines. Ann Rev Pharmacol Toxicol 1996;36:233 252
  • 21
    Simons FE, Bergman JN, Watson WT, Simons KJ. The clinical pharmacology of fexofenadine in children. J Allergy Clin Immunol 1996;98:1062 1064
  • 22
    Vincent J, Liminana R, Meredith PA, Reid JL. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol 1988;26:497 502
  • 23
    Roberts DJ. A preclinical overview of ebastine. Studies on the pharmacological properties of a novel histamine H1 receptor antagonist. Drugs 1996;52:8 14
  • 24
    Fugner A, Bechtel WD, Kuhn FJ, Mierau J. In vitro and in vivo studies of the non-sedating antihistamine epinastine . Arzneimittelforschung 1988;38:1446 1453
  • 25
    Bond A & Lader M. The use of analogue scales in rating subjective findings. Br J Psychol 1974;47:211 218
  • 26
    Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971
  • 27
    Steinijans VW & Diletti E. Statistical analysis of bioavailability studies: parametric and non-parametric confidence intervals. Eur J Clin Pharmacol 1983;24:127 136
  • 28
    Grant JA & Li H. Biology of basophils In: AdkinsonNF, BusseWW, EllisEF, MiddletonE, ReedCE, YungingerJW, editors. Allergy: principles and practice. 5th ed. St Louis, MO: Mosby-Year Book, 1998:277 284
  • 29
    Zhang MQ, Caldirola P, Timmerman H. Calcium antagonism and structure-affinity relationships of terfenadine, a histamine H1 antagonist, and some related compounds. J Pharm Pharmacol 1993;45:63 66
  • 30
    Snyder SH & Snowman AM. Receptor effects of cetirizine. Ann Allergy 1987;59:4 8
  • 31
    Dupont LJ, Meade CJ, Demedts MG, Verleden GM. Epinastine (WAL 801CL) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptor . Eur Respir J 1996;9:1433 1438
  • 32
    Kreutner W, Chapman RW, Gulbenkian A, Siegel MI. Antiallergic activity of loratadine, a non-sedating antihistamine. Allergy 1987;42:57 63
  • 33
    Adamus WS, Oldigs-kerber J, Lohmann H. Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers . Arzneimittelforschung 1987;37:569 572
  • 34
    Schilling JC, Adamus WS, Kuthan H. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 1990;28:493 497
  • 35
    De La Cuadra J, Teruel M, Teixido P, Roma J. Assessment of the wheal size and skin blood flow of the erythema induced by histamine and its modification with cetirizine and ebastine: a crossover, double-blind study. Dermatology 1994;188:131 134
  • 36
    Frossard N, Melac M, Benabdesselam O, Pauli G. Consistency of the efficacy of cetirizine and ebastine on skin reactivity. Ann Allergy Asthma Immunol 1998;80:61 65
  • 37
    Simons FER & Simons KJ. Peripheral H1-blockade effect of fexofenadine . Ann Allergy Asthma Immunol 1997;79:530 532
  • 38
    Allegra file. US Food and Drug Administration – NDA 20–265, Protocol JR004, Medical Officer Review, p. 18
  • 39
    Allegra file. US Food and Drug Administration – NDA 20–265, Summary of pharmacology, IND, p.17
  • 40
    Simons FE, Watson WT, Simons KJ. Pharmacokinetics and pharmacodynamics of ebastine in children. J Pediatr 1993;122:641 646